Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway.

Authors:
Liu L; Gao Y; Yao S.

Journal:
Invest Ophthalmol Vis Sci

Publication Year: 2024

DOI:
10.1167/iovs.65.1.45

PMCID:
PMC10833055

PMID:
38289614

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Invest Ophthalmol Vis Sci

Abbreviation: Invest Ophthalmol Vis Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
5-Aza-2'-Deoxycytidine Ameliorates Choroidal Neovascularization by Inhibiting the Wnt/β-Catenin Sig…
Wu X; Yang X; Dai X and 7 more (2024) - Transparency Score: 3/6
Adaptive Optics Retinal Imaging in RDH12-Associated Early Onset Severe Retinal Dystrophy.
Daich Varela M; Dixit M; Kalitzeos A and 1 more (2024) - Transparency Score: 3/6
A Novel Exploration of the Choroidal Vortex Vein System: Incidence and Characteristics of Posterior…
He G; Zhang X; Zhuang X and 8 more (2024) - Transparency Score: 2/6
Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma.
Zhang Y; Wu W; Xu C and 2 more (2024) - Transparency Score: 3/6
Applying Resampling and Visualization Methods in Factor Analysis to Model Human Spatial Vision.
Min SH; Reynaud A. (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure: L. Liu, None; Y. Gao, None; S. Yao, None"

Evidence found in paper:

"Funded by Tianjin Key Medical Discipline (Specialty) Construction Project (No. TJYXZDXK-016A)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025